ACE2 and COVID-19: It was recently reported that plasma of COVID-19 patients induced glycocalyx shedding, resulting in hyperinflammation and oxidative stress (Potje et al., 2021), while the glycocalyx damage allowed S-ACE2 binding, in turn enabling viral entry (Targosz-Korecka et al., 2021).